Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Brooklyn ImmunoTherapeutics Inc. BTX

Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells.


Top institutional share ownership of Brooklyn Immunotherapeutics Inc

Name Shares Shares % change Value Value % change
Armistice Capital, Llc 4,342,561 -21.0% $2,248 -80.1%
Cypress Point Wealth Management, LLC 1,887,509 0.0% $977 -74.8%
Naviter Wealth, LLC 1,572,803 0.1% $814 -74.7%
Renaissance Technologies Llc 1,215,800 108.8% $629 -47.3%
BlackRock Inc. 1,211,222 -49.2% $626 -87.2%
Inverness Counsel Llc /ny/ 1,210,537 0.0% $627 -74.7%
Vanguard Group Inc 1,140,870 -11.5% $590 -77.7%
Jpmorgan Chase & Co 803,842 -2.2% $416 -75.3%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 740,159 0.0% $383 -74.8%
IWM - iShares Russell 2000 ETF 674,548 -2.5% $1,383 -52.1%

Top institutional buyers of Brooklyn Immunotherapeutics Inc

Name Shares % change Value % change Shares Value
Two Sigma Investments, Lp 307.9% 3.9% 155,815 $81
Goldman Sachs Group Inc 144.1% -39.2% 94,138 $48
Renaissance Technologies Llc 108.8% -47.3% 1,215,800 $629
Allspring Global Investments Holdings, LLC 77.2% -12.7% 117,660 $241
BDSIX - BlackRock Advantage Small Cap Core Fund Institutional Shares 45.1% -57.0% 325,712 $218
Citadel Advisors Llc 21.6% -69.3% 206,844 $107
FSSNX - Fidelity Small Cap Index Fund 14.6% -55.8% 214,534 $225
IWO - iShares Russell 2000 Growth ETF 0.5% -50.6% 213,202 $437
Naviter Wealth, LLC 0.1% -74.7% 1,572,803 $814

Top institutional sellers of Brooklyn Immunotherapeutics Inc

Name Shares % change Value % change Shares Value
BlackRock Inc. -49.2% -87.2% 1,211,222 $626
Geode Capital Management, Llc -47.0% -86.6% 243,805 $126
Armistice Capital, Llc -21.0% -80.1% 4,342,561 $2,248
Vanguard Group Inc -11.5% -77.7% 1,140,870 $590
IBB - iShares Nasdaq Biotechnology ETF -3.2% -75.7% 179,264 $93
IWM - iShares Russell 2000 ETF -2.5% -52.1% 674,548 $1,383
Jpmorgan Chase & Co -2.2% -75.3% 803,842 $416

Information provided by Fintel.io